bromfenac has been researched along with Macular Degeneration in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mazur-Piotrowska, G; Piotrowska-Gwóźdź, A; Piotrowska-Seweryn, A; Rokicki, W; Wyględowska-Promieńska, D | 1 |
| Mazur-Piotrowska, G; Piotrowska-Gwóźdź, A; Piotrowska-Seweryn, A; Wyględowska-Promieńska, D | 1 |
| Flaxel, C; Francis, PJ; Hamon, SC; Schain, MB | 1 |
3 trial(s) available for bromfenac and Macular Degeneration
| Article | Year |
|---|---|
Combination of bevacizumab and bromfenac therapy in age-related macular degeneration: a pilot study.
Topics: Aged; Antibodies, Monoclonal, Humanized; Benzophenones; Bevacizumab; Bromobenzenes; Case-Control Studies; Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Macular Degeneration; Male; Pilot Projects; Retina; Subretinal Fluid; Tomography, Optical Coherence; Visual Acuity | 2014 |
Combination of Aflibercept and Bromfenac Therapy in Age-Related Macular Degeneration: A Pilot Study Aflibercept and Bromfenac in AMD.
Topics: Aged; Benzophenones; Bromobenzenes; Drug Therapy, Combination; Female; Humans; Macular Degeneration; Male; Pilot Projects; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Visual Acuity | 2015 |
Prospective randomized controlled trial of combination ranibizumab (Lucentis) and bromfenac (Xibrom) for neovascular age-related macular degeneration: a pilot study.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Benzophenones; Bromobenzenes; Female; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Ophthalmic Solutions; Pilot Projects; Prospective Studies; Ranibizumab; Visual Acuity | 2012 |